Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-25-030436
Filing Date
2025-04-10
Accepted
2025-04-10 08:00:11
Documents
18
Period of Report
2025-04-10

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER ea0237800-6k_alterity.htm 6-K 14062
2 ALTERITY PHASE 2 PRESENTATION AT AAN 2025 ea023780001ex99-1_alterity.htm EX-99.1 19744
3 GRAPHIC ex99-1_001.jpg GRAPHIC 479276
4 GRAPHIC ex99-1_002.jpg GRAPHIC 149131
5 GRAPHIC ex99-1_003.jpg GRAPHIC 495689
6 GRAPHIC ex99-1_004.jpg GRAPHIC 151302
7 GRAPHIC ex99-1_005.jpg GRAPHIC 452987
8 GRAPHIC ex99-1_006.jpg GRAPHIC 418492
9 GRAPHIC ex99-1_007.jpg GRAPHIC 505791
10 GRAPHIC ex99-1_008.jpg GRAPHIC 339756
11 GRAPHIC ex99-1_009.jpg GRAPHIC 370716
12 GRAPHIC ex99-1_010.jpg GRAPHIC 399456
13 GRAPHIC ex99-1_011.jpg GRAPHIC 342505
14 GRAPHIC ex99-1_012.jpg GRAPHIC 596735
15 GRAPHIC ex99-1_013.jpg GRAPHIC 284538
16 GRAPHIC ex99-1_014.jpg GRAPHIC 426086
17 GRAPHIC ex99-1_015.jpg GRAPHIC 424900
18 GRAPHIC ex99-1_016.jpg GRAPHIC 933653
  Complete submission text file 0001213900-25-030436.txt   9360182
Mailing Address LEVEL 3, 460 BOURKE STREET MELBOURNE C3 VIC 3000
Business Address LEVEL 3, 460 BOURKE STREET MELBOURNE C3 VIC 3000 61 3 9349 4906
ALTERITY THERAPEUTICS LTD (Filer) CIK: 0001131343 (see all company filings)

EIN.: 000000000 | State of Incorp.: C3 | Fiscal Year End: 0630
Type: 6-K | Act: 34 | File No.: 000-49843 | Film No.: 25826526
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)